Home

Course of disease

Alzheimer's Disease

Read time: 4 min

Biomarkers to enable early diagnosis and intervention and to monitor progression

Clinical diagnosis of Alzheimer’s disease (AD) is difficult and has an error rate of 40%....

Bipolar, Schizophrenia

Read time: 4 min

Congress highlights

Antipsychotic treatment adherence improves functional outcome for bipolar I disorder and schizophrenia

A good functional outcome — improved cognition; ability to work, study, live independently,...

Bipolar, Schizophrenia

Read time: 3 min

Congress highlights

Reconceptualizing psychosis based on biomarker analysis – personalized therapy to prevent disease progression

When an extensive biomarker study characterizing diverse aspects of brain function unexpectedly...

Parkinson's Disease

Read time: 4 min

Congress highlights

Advances in Parkinson’s disease research: one step closer to identify subjects in the prodromal stage, predicting conversion and potential for disease-modifying therapy

The incidence of Parkinson’s disease (PD) is increasing. The reasons are unknown. Identifying...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Could astrocyte activation initiate AD pathology 20 years before diagnosis?

Neuroimaging techniques demonstrate a 20-year pathophysiological pathway preceding the development...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Dietary interventions that may lower the risk of Alzheimer’s disease

Increasing evidence shows that dietary interventions may lower the risk of developing Alzheimer...

Read time: 4 min

Congress highlights

Pros and cons of persisting with antipsychotic treatment: assessing the evidence

Guidelines recommend that people with first-episode psychosis should where possible be maintained...

Alzheimer's Disease

Read time: 3 min

Agitation should be a focus in dementia

In the past, “agitation” in the context of the dementias referred to a wide range of...

Read time: 1 min

Light in the darkness: Combating the mid-winter blues

Social, cultural, and even climatic factors can make the winter holidays particularly difficult for...

Alzheimer's Disease

Read time: 4 min

Biomarkers in trials and practice

The correlation between cerebrospinal fluid (CSF) and Positron Emission Tomography (PET) biomarkers...

Read time: 3 min

Perspectives on bipolar disorder

Reliable biomarkers and agreed clinical staging systems would both represent valuable steps towards...

Read time: 2 min

Value of Treatment: European Brain Council publishes landmark report

Greater clinical benefit for patients and gains in cost-effectiveness for society -- both can be...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country